Status:

UNKNOWN

Mechanically-Assisted and Non-Invasive Ventilation for Breathing-related Tumor Motion Mitigation.

Lead Sponsor:

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Conditions:

Optimization of Motion Mitigation Strategies by Mechanically-Assisted Non-Invasive Ventilation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Breathing motion still remains a major issue that jeopardizes the accuracy of photon- and proton-therapy for thoracic and upper-abdominal tumors, which represent up to 40% of curative radiotherapy tre...

Detailed Description

Radiotherapy of mobile tumors faces many challenges due to breathing-related geometrical uncertainties. Breathing amplitude and frequency may deeply and unexpectedly vary from cycle to cycle, during a...

Eligibility Criteria

Inclusion

  • Validation of the MANIV-optimized gating strategy for breasrt tumors :
  • Patients with left breast tumors eligible for radiation therapy with breath hold technique.
  • Validation of the MANIV optimized Gating strategy for lung/liver tumors:
  • Patients with lung (primary or secondary) or liver (primary or secondary) tumors eligible for stereotactic radiation therapy.
  • Validation of the MANIV-optimized Tracking strategy for liver tumors:
  • Part 1: Patients with hepatic neoplasia (primary or secondary) eligible for stereotactic radiation therapy on the Cyberknife® of the Oscar Lambret center in Lille (France)..
  • Part 2: Patients with hepatic neoplasia (primary or secondary) treated by respiratory tracking on the Cyberknife® of the Oscar Lambret center in Lille (France).
  • 4 - Evaluation of a proton therapy treatment delivered in silico to mobile tumors with MANIV in DIBH mode : Patients included in the study on the optimization of the Gating strategy.

Exclusion

  • history of spontaneous pneumothorax

Key Trial Info

Start Date :

July 3 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2024

Estimated Enrollment :

241 Patients enrolled

Trial Details

Trial ID

NCT04457102

Start Date

July 3 2020

End Date

September 30 2024

Last Update

June 1 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cliniques Universitaires Saint-Luc

Woluwe-Saint-Lambert, Brussels Capital, Belgium, 1200